Journal
/
/
High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
JoVE Journal
Cancer Research
Author Produced
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Cancer Research
High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
DOI:

13:59 min

August 18, 2023

, , , , ,

Chapters

  • 00:05Introduction
  • 01:02Protocol
  • 01:25Coating of the HCS plate
  • 02:04Seeding of JIMT-1 EGFP cells
  • 04:33Pre-treatment of JIMT-1 EGFP cells with compound library
  • 06:06Starting the ADCC assay by adding the effector cells
  • 09:16Imaging
  • 10:45Image analysis
  • 12:24Representative results
  • 13:15Discussion

Summary

Automatic Translation

This protocol presents an automated, image-based high-throughput technique to identify compounds modulating natural killer cell-mediated breast cancer cell killing in the presence of a therapeutic anti-HER-2 antibody.

Related Videos

Read Article